Literature DB >> 7427244

Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.

I N Olver, G L Jennings, A Bobik, M Esler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427244      PMCID： PMC1713839          DOI： 10.1136/bmj.281.6235.275-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  9-10-dihydroergotamine: production of antibodies and radioimmunoassay.

Authors:  J Rosenthaler; H Munzer
Journal:  Experientia       Date:  1976-02-15

2.  Treatment of orthostatic hypotension with dihydroergotamine.

Authors:  G Jennings; M Esler; R Holmes
Journal:  Br Med J       Date:  1979-08-04

3.  The sympathetic-nervous-system defect in primary orthostatic hypotension.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

4.  Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.

Authors:  W H Aellig; E Nüesch
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-03
  4 in total
  6 in total

1.  Pharmacological actions of the main metabolites of dihydroergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Treatment of postural hypotension. A review.

Authors:  R A Ahmad; R D Watson
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  Bioavailability of dihydroergotamine in man.

Authors:  P J Little; G L Jennings; H Skews; A Bobik
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion.

Authors:  B Lindblad; E Abisch; D Bergqvist
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Video education to improve clinical skills in the prevention of and response to vasovagal syncopal episodes.

Authors:  Anne Coakley; Alison Bailey; Joy Tao; Yujie L Liou; Amanda Champlain; Michael Ander; Eden Lake
Journal:  Int J Womens Dermatol       Date:  2020-02-15

6.  Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure.

Authors:  Amy C Arnold; Claudia E Ramirez; Leena Choi; Luis E Okamoto; Alfredo Gamboa; André Diedrich; Satish R Raj; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  Front Physiol       Date:  2014-07-24       Impact factor: 4.566
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.